<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peripheral blood (PB) granulocyte-macrophage progenitor (CFU-GM) growth was measured in 47 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and, together with bone marrow CFU-GM and blast cell numbers, in 45 newly diagnosed patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Both PB colony and cluster numbers were significantly reduced in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>In patients with greater than 5% marrow blasts there was a negative correlation between blast cell numbers and PB colony growth </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow and PB colony growth were also well correlated in this group </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001510'>Poor growth</z:hpo> of PB CFU-GM appears to be more closely related to prognosis than does bone marrow progenitor growth </plain></SENT>
</text></document>